News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
653,429 Results
Type
Article (48952)
Company Profile (256)
Press Release (604221)
Section
Business (189542)
Career Advice (2647)
Deals (34301)
Drug Delivery (117)
Drug Development (81501)
Employer Resources (162)
FDA (16658)
Job Trends (14197)
News (331307)
Policy (33704)
Tag
Academia (2519)
Alliances (47049)
Alzheimer's disease (1344)
Approvals (16582)
Artificial intelligence (159)
Bankruptcy (332)
Best Places to Work (10596)
Biotechnology (138)
Breast cancer (191)
Cancer (1412)
Cardiovascular disease (115)
Career advice (2203)
CAR-T (103)
Cell therapy (303)
Clinical research (65160)
Collaboration (481)
Compensation (264)
COVID-19 (2656)
C-suite (114)
Data (1376)
Diabetes (181)
Diagnostics (5763)
Drug pricing (106)
Earnings (74738)
Employer resources (147)
Events (98728)
Executive appointments (389)
FDA (17343)
Funding (411)
Gene therapy (211)
GLP-1 (700)
Government (4180)
Healthcare (17035)
Infectious disease (2753)
Inflammatory bowel disease (117)
Interviews (477)
IPO (15841)
Job creations (4003)
Job search strategy (1857)
Layoffs (471)
Legal (8238)
Lung cancer (209)
Manufacturing (225)
Medical device (12239)
Medtech (12243)
Mergers & acquisitions (18623)
Metabolic disorders (518)
Neuroscience (1689)
NextGen Class of 2024 (5856)
Non-profit (3718)
Northern California (1647)
Obesity (301)
Opinion (238)
Patents (123)
People (55124)
Phase I (20010)
Phase II (28338)
Phase III (21951)
Pipeline (528)
Postmarket research (2804)
Preclinical (8284)
Radiopharmaceuticals (239)
Rare diseases (277)
Real estate (5739)
Regulatory (22829)
Research institute (2314)
Resumes & cover letters (439)
Southern California (1396)
Startups (3464)
United States (14685)
Vaccines (651)
Weight loss (238)
Date
Today (3)
Last 7 days (606)
Last 30 days (2368)
Last 365 days (34888)
2024 (34722)
2023 (39132)
2022 (50081)
2021 (54091)
2020 (51696)
2019 (42876)
2018 (32750)
2017 (32517)
2016 (31563)
2015 (35660)
2014 (29174)
2013 (24460)
2012 (26480)
2011 (27240)
2010 (25334)
Location
Africa (808)
Arizona (166)
Asia (40680)
Australia (6527)
California (3660)
Canada (1348)
China (306)
Colorado (168)
Connecticut (191)
Europe (91655)
Florida (516)
Georgia (133)
Illinois (359)
Indiana (218)
Maryland (626)
Massachusetts (2928)
Michigan (148)
Minnesota (262)
New Jersey (1092)
New York (1034)
North Carolina (777)
Northern California (1647)
Ohio (129)
Pennsylvania (873)
South America (1201)
Southern California (1396)
Texas (533)
Washington State (385)
653,429 Results for "covis pharma holdings s a r l".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Deals
Two Private Equity Firms Near Potential $3B+ Deal for Mitsubishi’s Pharma Unit: Reuters
Blackstone and Bain Capital are said to be among the final bidders for the Japanese company’s Mitsubishi Tanabe Pharma, sources told Reuters Friday.
December 13, 2024
·
1 min read
·
Annalee Armstrong
Deals
Frontage Laboratories Acquires Accelera S.r.l.'s Bioanalytical and DMPK Businesses
Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera).
January 2, 2024
·
5 min read
Business
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.
August 26, 2024
·
5 min read
Press Releases
Nxera Pharma’s Partner Centessa Initiates Phase 2 Trial with ORX750, a Novel Orexin Receptor 2 (OX2R) Agonist
November 12, 2024
·
4 min read
Mergers & acquisitions
Novo Holdings Gets FTC’s Go-Ahead for Contentious $16.5B Catalent Acquisition
Now that they’ve received the go-signal from both U.S. and EU anti-trust regulators, Novo Holdings and Catalent expect to wrap up their deal in the coming days.
December 16, 2024
·
2 min read
·
Tristan Manalac
Business
Analysts Tell Moderna Investors to Hold After 2024’s Steep Drop
The vaccine maker previously revealed plans to slash R&D budget to conserve cash for product launches, but after a rough year of consistent share value decline, analysts remain skeptical.
December 17, 2024
·
3 min read
·
Kate Goodwin
Press Releases
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker
November 12, 2024
·
6 min read
1 of 65,343
Next
